NIH/National Institute of Allergy and Infectious Diseases

NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.

Address
NIAID Office of Communications and Government Relations 6610 Rockledge Drive, MSC 6612 Bethesda, MD 20892-6612 United States of America
Website
http://www3.niaid.nih.gov/
Wikipedia
http://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseases

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Neuroscience

Scientists develop 'mini-brain' model of human prion disease

National Institutes of Health scientists have used human skin cells to create what they believe is the first cerebral organoid system, or "mini-brain," for studying sporadic Creutzfeldt-Jakob disease (CJD). CJD is a fatal ...

Diseases, Conditions, Syndromes

Human antibody reveals hidden vulnerability in influenza virus

The ever-changing "head" of an influenza virus protein has an unexpected Achilles heel, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. ...

HIV & AIDS

In rare cases, immune system fails despite HIV suppression

Antiretroviral therapy (ART) is usually very effective at suppressing HIV in the body, allowing a person's immune system to recover by preventing the virus from destroying CD4+ T cells. Scientists have now identified a rare, ...

HIV & AIDS

Novel antibody may suppress HIV for up to four months

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) ...

page 1 from 35